Testing bias in clinical databases: Methodological considerations

Emerging Themes in Epidemiology

Volumn 7, Issue , 2010, Pages

  Velthove, Karin J ^a,b   Leufkens, Hubert Gm ^a   Souverein, Patrick C ^a   Schweizer, René C ^b   Van Solinge, Wouter W ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; BLOOD EXAMINATION; CARDIOVASCULAR DISEASE; DATA BASE; DRUG USE; ERROR; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; TESTING BIAS; UTRECHT PATIENT ORIENTED DATABASE;

EID: 77952085061     PISSN: None     EISSN: 17427622     Source Type: Journal    
DOI: 10.1186/1742-7622-7-2     Document Type: Article

References (24)

1. Clinical information for research; the use of general practice databases. R Lawrenson T Williams R Farmer, J Public Health Med 1999 21 299 304 10.1093/pubmed/21.3.299 10528957
2. Applications of artificial intelligence systems in the analysis of epidemiological data. AD Flouris J Duffy, Eur J Epidemiol 2006 21 167 70 10.1007/s10654-006-0005-y 16547830
3. A review of uses of health care utilization databases for epidemiologic research on therapeutics. S Schneeweiss J Avorn, J Clin Epidemiol 2005 58 323 37 10.1016/j.jclinepi.2004.10.012 15862718
4. Assessing observational studies of medical treatments. A Hartz S Bentler M Charlton D Lanska Y Butani GM Soomro K Benson, Emerg Themes Epidemiol 2005 2 8 10.1186/1742-7622-2-8 16137327
5. Methodologic challenges to studying patient safety and comparative effectiveness. BL Strom, Med Care 2007 45 13 5 10.1097/MLR.0b013e318041f752 17909371
6. Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark. C De Luise SF Lanes J Jacobsen L Pedersen HT Sorensen, Eur J Epidemiol 2007 22 267 72 10.1007/s10654-007-9106-5 17342451
7. Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour. S Rosso F Ricceri L Terracini R Zanetti, Emerg Themes Epidemiol 2009 6 2 10.1186/1742-7622-6-2 19250518
8. Diagnostic research on routine care data: prospects and problems. R Oostenbrink KG Moons SE Bleeker HA Moll DE Grobbee, J Clin Epidemiol 2003 56 501 6 10.1016/S0895-4356(03)00080-5 12873643
9. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. KW Bloemenkamp FR Rosendaal HR Buller FM Helmerhorst LP Colly JP Vandenbroucke, Arch Intern Med 1999 159 65 70 10.1001/archinte.159.1.65 9892332
10. Second manifestations of ARTerial disease (SMART) study: rationale and design. P Simons A Algra M Van de Laak D Grobbee Y Van der Graaf, Eur J Epidemiol 1999 15 773 81 10.1023/A:1007621514757 10608355
11. Systemic markers of inflammation in stable bronchiectasis. CB Wilson PW Jones CJ O'Leary DM Hansell RB Dowling PJ Cole R Wilson, Eur Respir J 1998 12 820 4 10.1183/09031936.98.12040820 9817152
12. Neutrophilic inflammation in severe persistent asthma. A Jatakanon C Uasuf W Maziak S Lim K Chung P Barnes, Am J Respir Crit Care Med 1999 160 1532 9 10556116
13. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. M Haumer J Amighi M Exner W Mlekusch S Sabeti O Schlager I Schwarzinger O Wagner E Minar M Schillinger, J Vasc Surg 2005 41 610 7 10.1016/j.jvs.2005.01.013 15874924
14. Hematocytometry analysis as discriminative marker for asthma phenotypes. KJ Velthove WW Van Solinge JW Lammers HG Leufkens RC Schweizer M Bracke, Clin Chem Lab Med 2009 47 573 8 10.1515/CCLM.2009.139 19397484
15. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. MJ Ten Berg A Huisman PM Van den Bemt AF Schobben AC Egberts WW Van Solinge, Clin Chem Lab Med 2007 45 13 9 10.1515/CCLM.2007.009 17243908
16. Anonymous, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), National Center for Health Statistics 2006
17. Asthma: defining of the persistent adult phenotypes. SE Wenzel, Lancet 2006 368 804 13 10.1016/S0140-6736(06)69290-8 16935691
18. Difficult/therapy-resistant asthma. The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-resistant asthma. K Chung P Godard E Adelroth J Ayres N Barnes P Barnes E Bel P Burney P Chanez G Connett C Corrigan J De Blic L Fabbri S Holgate P Ind G Joos H Kerstjens P Leuenberger C-G Lofdahl S McKenzie H Magnussen D Postma M Saetta S Salmeron M Silverman P Sterk, Eur Respir J 1999 13 1198 208 10414427
19. Neutrophil counts, monocyte counts and cardiovascular disease in the elderly. EM Pinto FA Huppert K Morgan C Mrc C Brayne, Exp Gerontol 2004 39 615 9 10.1016/j.exger.2003.12.011 15050297
20. Neutrophil function in ischemic heart disease. J Mehta J Dinerman P Mehta TG Saldeen D Lawson WH Donnelly R Wallin, Circulation 1989 79 549 56 2537159
21. Validating the effects of drug treatment on blood pressure in the General Practice Research Database. JA Delaney EE Moodie S Suissa, Pharmacoepidemiol Drug Saf 2008 17 535 45 10.1002/pds.1553 18265414
22. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. JD Lewis C Brensinger, Pharmacoepidemiol Drug Saf 2004 13 437 41 10.1002/pds.902 15269927
23. Investigation of relation between use of oral contraceptives and thromboembolic disease. MP Vessey R Doll, BMJ 1968 2 199 205 10.1136/bmj.2.5599.199 5653025
24. Bias in analytic research. DL Sackett, J Chronic Dis 1979 32 51 63 10.1016/0021-9681(79)90012-2 447779